Research Article

Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent

Volume: 43 Number: 3 September 1, 2023
EN TR

Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent

Abstract

A simple, specific and sensitive spectrophotometric method is presented for the determination of Mesalazine (MZN) based on diazotization in an acidic medium through reaction with sodium nitrite (NaNO2) to form a diazonium salt that coupling reaction in a base medium with 2,7-Dihydroxynaphthalene (DHNP) to form an azo dye. The dye intensity was measured at 501 nm after optimization of the experimental parameters. Beer’s law was applied to the proposed method, valid within a concentration range of 0.25–10 μg.mL-1, and the linear regression was R2 = 0.9974. The limit of detection (LOD), the limit of quantification (LOQ), the molar absorptivity coefficient were 0.074 μg.mL-1,0.249 μg.mL-1 and 1.85x104 L.mol−1.cm−1, respectively. Sandell's sensitivity was 0.0082μg.cm-2. There is no interference from excipients found in the tablet. The data were statistically compared with the British Pharmacopeia using two statistical methods (t-test and F-test).

Keywords

References

  1. [1] Y. Li et al., “Addition of berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL/6 mice,” PLoS One, vol. 10, no. 12, p. e0144101, 2015.
  2. [2] O. H. Nielsen and L. K. Munck, “Drug insight: aminosalicylates for the treatment of IBD,” Nat. Clin. Pract. Gastroenterol. Hepatol., vol. 4, no. 3, pp. 160–170, 2007.
  3. [1] Y. Li et al., “Addition of berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL/6 mice,” PLoS One, vol. 10, no. 12, p. e0144101, 2015.
  4. [2] O. H. Nielsen and L. K. Munck, “Drug insight: aminosalicylates for the treatment of IBD,” Nat. Clin. Pract. Gastroenterol. Hepatol., vol. 4, no. 3, pp. 160–170, 2007.
  5. [3] H. H. Abdu-Allah, A. N. El-Shorbagi, S. G. Abdel-Moty, R. El-Awady, and A. A. Abdel-Alim, “5-Aminosalyclic acid (5-ASA): a unique anti-inflammatory salicylate,” Med Chem (Los Angeles), vol. 6, pp. 306–315, 2016.
  6. [4] I. M. Balmus, A. Ciobica, A. Trifan, and C. Stanciu, “The implications of oxidative stress and antioxidant therapies in inflammatory bowel disease: clinical aspects and animal models,” Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc., vol. 22, no. 1, p. 3, 2016.
  7. [5] A. B. Teradale, S. D. Lamani, P. S. Ganesh, B. E. K. Swamy, and S. N. Das, “CTAB immobilized carbon paste electrode for the determination of mesalazine: a cyclic voltammetric method,” Sens. bio-sensing Res., vol. 15, pp. 53–59, 2017.
  8. [6] A. G. Tavares Junior, J. T. C. de Araújo, A. B. Meneguin, and M. Chorilli, “Characteristics, properties and analytical/bioanalytical methods of 5-aminosalicylic acid: a review,” Crit. Rev. Anal. Chem., pp. 1–15, 2020.

Details

Primary Language

English

Subjects

Analytical Chemistry

Journal Section

Research Article

Publication Date

September 1, 2023

Submission Date

June 13, 2022

Acceptance Date

May 8, 2023

Published in Issue

Year 2023 Volume: 43 Number: 3

APA
Maseer, A., & Najem, M. (2023). Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent. Hacettepe University Journal of the Faculty of Pharmacy, 43(3), 195-203. https://doi.org/10.52794/hujpharm.1129852
AMA
1.Maseer A, Najem M. Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent. HUJPHARM. 2023;43(3):195-203. doi:10.52794/hujpharm.1129852
Chicago
Maseer, Aws, and Moath Najem. 2023. “Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent”. Hacettepe University Journal of the Faculty of Pharmacy 43 (3): 195-203. https://doi.org/10.52794/hujpharm.1129852.
EndNote
Maseer A, Najem M (September 1, 2023) Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent. Hacettepe University Journal of the Faculty of Pharmacy 43 3 195–203.
IEEE
[1]A. Maseer and M. Najem, “Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent”, HUJPHARM, vol. 43, no. 3, pp. 195–203, Sept. 2023, doi: 10.52794/hujpharm.1129852.
ISNAD
Maseer, Aws - Najem, Moath. “Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent”. Hacettepe University Journal of the Faculty of Pharmacy 43/3 (September 1, 2023): 195-203. https://doi.org/10.52794/hujpharm.1129852.
JAMA
1.Maseer A, Najem M. Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent. HUJPHARM. 2023;43:195–203.
MLA
Maseer, Aws, and Moath Najem. “Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent”. Hacettepe University Journal of the Faculty of Pharmacy, vol. 43, no. 3, Sept. 2023, pp. 195-03, doi:10.52794/hujpharm.1129852.
Vancouver
1.Aws Maseer, Moath Najem. Spectrophotometric Determination of Mesalazine in Pure Form and Pharmaceutical Formulations by Diazotization and Coupling With 2,7-Dihydroxynaphthalene As a New Coupling Agent. HUJPHARM. 2023 Sep. 1;43(3):195-203. doi:10.52794/hujpharm.1129852